Lexaria Bioscience Corp.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2023
Total Assets: $3.1M
Liabilities Breakdown FY2023
Total Liabilities: $403.9K
Asset Breakdown
Total Assets: $3.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.4M | 43.8% |
| Accounts Receivable | $126.7K | 4.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $254.1K | 8.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $462.6K | 15.0% |
| Other Assets | $888.4K | 28.8% |
Liabilities Breakdown
Total Liabilities: $403.9K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $239.9K | 59.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $164.0K | 40.6% |